Idamycin PFS (Idarubicin) for Leukemia

Overview

Idamycin PFS is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in adults. Idamycin PFS is often combined with other drugs such as cytarabine in specific chemotherapy regimens. Idamycin PFS is also known by its drug name, iIdarubicin. Idamycin PFS is an anticancer drug used in chemotherapy. Idamycin PFS is a member of a drug class called anthracycline antibiotics. Idamycin PFS is also a topoisomerase inhibitor. Idamycin PFS is believed to work by damaging DNA and blocking cell division in several different ways.

How do I take it?

Idamycin PFS is administered as an intravenous infusion during chemotherapy treatment.

Side effects

The FDA-approved label for Idamycin PFS lists common side effects including frequent infections, hair loss, nausea, vomiting, diarrhea, abdominal cramps, mouth sores, and abnormal bleeding. Rare but serious side effects listed for Idamycin include heart failure, severe damage to skin at injection sites, and fetal harm in pregnant women.

For more details about this treatment, visit:

Idamycin PFS — Pfizer

AML: Chemotherapy and Drug Therapy — Leukemia & Lymphoma Society